VBI Vaccines Inc. is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Our FDA-approved prophylactic hepatitis B (HBV) vaccine is the only 3-antigen HBV vaccine for adults. Leveraging our innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, we also have a pipeline of developmental-stage candidates targeting the treatment of chronic HBV infection, glioblastoma (GBM), and the prevention of COVID-19 and coronaviruses